Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Feuerstein

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of Cellular Biochemistry|July 1, 1991
Fluorescent tetradecanoylphorbol acetate: a novel probe of phorbol ester binding domainsM Balázs, J Szöllösi, W C Lee, et al.
American Journal of Clinical Pathology|December 10, 1999
Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomasA Perry, K Anderl, T J Borell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 15, 2001
Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sectionsP C Burger, A Y Minn, J S Smith, et al.
AJNR. American Journal of Neuroradiology|December 6, 2008
Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurementsL S Hu, L C Baxter, K A Smith, et al.
Oncogene|July 20, 2007
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signatureN Tomioka, S Oba, M Ohira, et al.
Medical and Pediatric Oncology|July 24, 2001
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?J Vandesompele, F Speleman, N Van Roy, et al.
Oncogene|August 6, 1999
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeJ S Smith, B Alderete, Y Minn, et al.
AJNR. American Journal of Neuroradiology|November 19, 2011
Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade gliomaL S Hu, J M Eschbacher, A C Dueck, et al.
AJNR. American Journal of Neuroradiology|September 15, 2009
Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomasL S Hu, L C Baxter, D S Pinnaduwage, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Cellular Biochemistry|July 1, 1991
Fluorescent tetradecanoylphorbol acetate: a novel probe of phorbol ester binding domainsM Balázs, J Szöllösi, W C Lee, et al.
American Journal of Clinical Pathology|December 10, 1999
Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomasA Perry, K Anderl, T J Borell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 15, 2001
Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sectionsP C Burger, A Y Minn, J S Smith, et al.
AJNR. American Journal of Neuroradiology|December 6, 2008
Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurementsL S Hu, L C Baxter, K A Smith, et al.
Oncogene|July 20, 2007
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signatureN Tomioka, S Oba, M Ohira, et al.
Medical and Pediatric Oncology|July 24, 2001
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?J Vandesompele, F Speleman, N Van Roy, et al.
Oncogene|August 6, 1999
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeJ S Smith, B Alderete, Y Minn, et al.
AJNR. American Journal of Neuroradiology|November 19, 2011
Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade gliomaL S Hu, J M Eschbacher, A C Dueck, et al.
AJNR. American Journal of Neuroradiology|September 15, 2009
Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomasL S Hu, L C Baxter, D S Pinnaduwage, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Pageof 7